| Product Name | MF | CAS | Details |
|---|
| (+/-)-Vestitol | C16H16O4 | 56701-24-7 | Details |
| Tosufloxacin toluenesulfonate | C26H23F3N4O6S | 115964-29-9 | Details |
| ZNF724P Blocking Peptide | Details |
| Anti-Kairi Virus (KRIV) Nucleocapsid ant - 0.2mg/mL | Details |
| 3-(Cyclohexylamino)propan-1-ol hydrochloride | C9H20ClNO | 2305255-78-9 | Details |
| 2-(1,4-Diazepan-1-yl)acetamide dihydrochloride | C7H16ClN3O | 1171720-80-1 | Details |
| AHNAK antibody | Details |
| 1-(3,4-Difluorophenyl)-2,2-dimethoxyethan-1-ol | C10H12F2O3 | 1461708-78-0 | Details |
| 3,4-Dihydroxy-5-nitrobenzaldehyde | C7H5NO5 | 116313-85-0 | Details |
| cis-Propenylphosphonic acid | C3H7O3P | 25383-06-6 | Details |
| 3-(3,4-Dimethylbenzenesulfonamido)propanoic acid | C11H15NO4S | 459414-01-8 | Details |
| (4-Chlorophenyl)(naphthalen-2-yl)methanamine hydrochloride | C17H14ClN.ClH | 2247107-87-3 | Details |
| N,1-Dibenzylpiperidin-4-amine | C19H24N2 | 202198-91-2 | Details |
| Mycoplasma pneumoniae protein | Details |
| bZIP23 antibody | Details |
| SGCD protein (His tag) | Details |
| MLS 1547 | C19H19ClN4O | 315698-36-3 | Details |
| Human IL17 ELISA Kit | Details |
| 4-(Piperidin-3-yl)morpholine dihydrochloride | C9H20Cl2N2O | 1124199-56-9 | Details |
| 3-(2-Methoxybenzyl)piperidine | C13H19NO | 420137-10-6 | Details |
| 4-Nitrophenyl 4-tolyl ether | C13H11NO3 | 3402-74-2 | Details |
| [Lys15]-Amyloid beta-Protein (15-21) | C44H69N9O8 | Details |
| 2-Fluoro-6-(methylsulfanyl)benzoic acid | C8H7FO2S | 1516052-88-2 | Details |
| 3'-Methoxy-6'-[(4-nitrophenyl)methoxy]-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one | C28H19NO7 | 2206677-06-5 | Details |
| 2-Hydroxy-6-methoxybenzoic acid methyl ester | C9H10O4 | 22833-69-8 | Details |
| WY-135 | C28H34ClN9O3S | 2163060-83-9 | Details |
| 2,5-Dichloro-4-methylaniline | C7H7Cl2N | 88434-66-6 | Details |
| 3-(Methoxymethyl)-3-methylpyrrolidine hydrochloride | C7H16ClNO | 1820705-20-1 | Details |
| H-RGSGR-OH | Details |
| 2-(4-Methylpiperazin-1-yl)pyrimidine-5-carbaldehyde | C10H14N4O | 1340381-82-9 | Details |
| Vasoactive Intestinal Contractor [VIC] | Details |
| Cedrelone | C26H30O5 | 1254-85-9 | Details |
| Methyl 3,4,5-trimethoxycinnamate | C13H16O5 | 7560-49-8 | Details |
| 5,6-Dibromo-1,3-benzodioxole | C7H4Br2O2 | 5279-32-3 | Details |
| 2-Amino-5-fluoro-N-methoxy-N-methylbenzamide | C9H11FN2O2 | 880875-39-8 | Details |
| Methyl 5-(chlorosulfonyl)-2-iodobenzoate | C8H6ClIO4S | 1065102-81-9 | Details |
| SARS-CoV-2 Antibody Negative Human Plasma | Details |
| 2-Cyclopropyl-4-(dimethoxymethyl)pyrimidine | C10H14N2O2 | 914348-07-5 | Details |
| 2,6-Diamino-9-(2'[2-methylacetamido]-b-D-ribofuranosyl)purine | Details |
| H-GGPESFYCASW-OH | Details |
| 4-(4-Chlorophenyl)-2-pyrrolidinone | C10H10ClNO | 22518-27-0 | Details |
| Otosenine | C19H27NO7 | 16958-29-5 | Details |
| 3-Azabicyclo[4.2.1]nonane-3-carboxamide | 2289818-04-6 | Details |
| 5-(Methoxycarbonyl)bicyclo[3.2.1]octane-1-carboxylic acid | C11H16O4 | 110371-27-2 | Details |
| LOC645015 Blocking Peptide | Details |
| (3R,6S,9S,12E,16S)-9-(4-Aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,15-pentaazacycloe icos-12-ene-16-carboxamide | C43H56F3N7O9 | 1774353-12-6 | Details |
| Salicylhydrazide | C7H8N2O2 | 936-02-7 | Details |
| Inosine-3',5'-cyclic-monophosphate sodium | C10H12N4NaO7P | 41092-64-2 | Details |
| 2-[(2E)-3-(Pyridin-3-yl)prop-2-enamido]acetic acid | C10H10N2O3 | 1099119-78-4 | Details |
| 2-Cyano-1-benzothiophene-3-sulfonyl chloride | C9H4ClNO2S2 | 1334626-84-4 | Details |
| 6-Bromo-2-(oxolan-2-yl)-4H-imidazo[4,5-b]pyridine | C10H10BrN3O | 1250609-87-0 | Details |
| 4-Nitrobenzamide | C7H6N2O3 | 619-80-7 | Details |
| IL22 protein | Details |
| H-YHPNGMNPYTKA-NH2 | Details |
| Scoparinol | C27H38O4 | 130838-00-5 | Details |
| 3,5,6-Tri-O-benzyl-D-glucofuranose | C27H30O6 | 81969-62-2 | Details |
| 3-Deoxy-1,2-O-isopropylidene-5-p-toluoyl-b-L-threo pentofuranose | Details |
| Bis(4-(4-methoxyphenyl)piperazine-1-carboximidamide), sulfuric acid | C24H38N8O6S | 1384428-70-9 | Details |
| 1-(Thiophen-3-ylmethyl)piperidin-4-amine | C10H16N2S | 933737-29-2 | Details |
| 3-methoxy-isoxazole-5-carboxylic acid | C5H5NO4 | 13626-59-0 | Details |
| [1-(3-Aminopyridin-2-yl)piperidin-4-yl]methanol | C11H17N3O | 1094233-96-1 | Details |
| 1,2-Dihydro-2,6-naphthyridin-3(4H)-one | C8H8N2O | 37125-44-3 | Details |
| N-(2-Chloro-4-fluorophenyl)-2-chloropropanamide | C9H8Cl2FNO | 571153-08-7 | Details |
| 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole | C11H9N3S | 172152-53-3 | Details |
| 4-Hydroxy-4-methyl-2-pentanone | C6H12O2 | 123-42-2 | Details |
| 1,2,6-Thiadiazinane 1,1-dioxide | C3H8N2O2S | 67104-89-6 | Details |
| Furo[2,3-c]pyridine-7(6H)-one | C7H5NO2 | 84400-98-6 | Details |
| G3BP antibody | Details |
| Eotaxin 3 antibody (biotin) | Details |
| Dog Alpha 1-Acid Glycoprotein ELISA Kit | Details |
| 7-Oxa-1,3-diazaspiro[4.5]decane-2,4-dione | C7H10N2O3 | 1342660-34-7 | Details |
| 4-Amino-8-oxa-2-azaspiro[4.5]decan-3-one | C8H14N2O2 | 2089255-18-3 | Details |
| Donkey anti Rat IgG (H + L) (Fab'2) (biotin) | Details |
| Carboxyl-dPEG?4-(m-dPEG?12)3 | 1334178-04-9 | Details |
| 1-Bromo-3-propoxybenzene | C9H11BrO | 149557-17-5 | Details |
| methyl 3,4,5-trimethoxy-2-((phenylcyclopentyl)carbonylamino)benzoate | C23H27NO6 | 1024040-65-0 | Details |
| Chroman-3-one | C9H8O2 | 19090-04-1 | Details |
| 5-Amino-1-(2-ethylphenyl)-1H-pyrazole-4-carbonitrile | C12H12N4 | 792953-03-8 | Details |
| 6-Acetyl-1,2,3,4-tetrahydroquinoxaline-2,3-dione | C10H8N2O3 | 1018458-42-8 | Details |
| N-Cadherin antibody | Details |
| Lgi2 Blocking Peptide | Details |
| 2-[(Carbamoylmethyl)(4-formylphenyl)amino]acetic acid | C11H12N2O4 | 2059955-37-0 | Details |
| H-SAEGLDASASLR^-OH | Details |
| H-RAHYNI^VTF-OH | Details |
| 6-Hydroxy-3-oxabicyclo[3.3.1]nonan-9-one | C8H12O3 | 851984-06-0 | Details |
| 3-Chloro-6-(4-methyl-1H-imidazol-1-yl)pyridazine | C8H7ClN4 | 941294-26-4 | Details |
| 5-(Carboxymethyl)pyridine-2-carboxylic acid | C8H7NO4 | 162368-24-3 | Details |
| Tlr7 agonist 3 | C18H24N4O | 1229024-78-5 | Details |
| CTX-712 | C19H17FN8O2 | 2144751-78-8 | Details |
| HIST1H3A antibody | Details |
| 2-((2-Chlorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid | C11H9ClN2O2S | 436094-68-7 | Details |
| 5-Bromo-4-fluoro-1,3-dimethyl-1H-pyrazole | C5H6BrFN2 | 1909313-35-4 | Details |
| H-LYLVCGERV-OH | Details |
| 2-Amino-5-(4-chlorophenoxy)benzoic acid | C13H10ClNO3 | 117297-52-6 | Details |
| 2-(Benzylamino)pyridine-4-carboxylic acid | C13H12N2O2 | 1019372-91-8 | Details |
| [Phe17]-Apelin 17 | C96H156N34O20S | Details |
| rac-Methyl (2R,4S)-8,9-diazatricyclo[4.3.0.0,2,4]nona-1(6),7-diene-4-carboxylate | C9H10N2O2 | 2138065-50-4 | Details |
| 2,2-Dimethyl-1,2-dihydroquinolin-4-ol hydrochloride | C11H14ClNO | 1824590-18-2 | Details |
| 3-(1,2,3,4-Tetrahydroquinoline-1-carbonyl)aniline | C16H16N2O | 137975-41-8 | Details |
| rac-tert-Butyl N-[(3R,4S)-4-(4-amino-1H-pyrazol-1-yl)oxolan-3-yl]carbamate | C12H20N4O3 | 2174002-68-5 | Details |
| Product Total： Product Page： | ||||
| 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 | ||||